Apolipoprotein B-100 gene mutations and cholesterol control in German patients.
Loggen
Ursula
U
Boden
Anja
A
Baron
Heike
H
Schuster
Herbert
H
Tolle
Ralf
R
Netwich
Ulrike
U
Dupon
Cecile
C
Müller-Myhsok
Bertram
B
Baron
Heike
H
Luft
Friedrich C
FC
D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D000368:Aged; D000704:Analysis of Variance; D053299:Apolipoprotein B-100; D001055:Apolipoproteins B / Q000235:genetics*; D002648:Child; D002675:Child, Preschool; D008078:Cholesterol, LDL / Q000032:analysis; D003324:Coronary Artery Disease / Q000517:prevention & control*; D005260:Female; D005787:Gene Frequency; D005819:Genetic Markers; D005858:Germany; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology*; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D015994:Incidence; D007223:Infant; D008297:Male; D008403:Mass Screening; D008875:Middle Aged; D009154:Mutation; D016133:Polymerase Chain Reaction; D011336:Probability; D018570:Risk Assessment; D017678:Sex Distribution
D053299:Apolipoprotein B-100; D001055:Apolipoproteins B; D008078:Cholesterol, LDL; D005819:Genetic Markers; D000960:Hypolipidemic Agents